One thing going for Acadia is: The company noted that because it distributes Nuplazid through a specialty distribution channel, Acadia has frequent contact with patients and caregivers regarding adverse events.
I looks as though they will have the means to get Trof out into the market through existing channels. With the current concerns around Nuplazid they will need to get Trofinetide out to market asap.
Hoping we see some level of recovery today and not a further slide.
Ann: Neuren and ACADIA announce agreement for North America, page-199
-
- There are more pages in this discussion • 298 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.620(2.99%) |
Mkt cap ! $2.569B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $19.92 | $5.947M | 296.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | $20.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.19 | 10 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |